PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Diagnostic Imaging
Interventions: DRUG: BAY86-9596|DRUG: BAY86-9596|DRUG: BAY86-9596|DRUG: Fludeoxyglucose (18F)-IBA
Sponsor: Life Molecular Imaging SA